The CCI Wednesday dismissed a complaint alleging unfair business practices against the Ministry of Health and Family Welfare and the CMSS with regard to agreement for providing male contraceptives.
The Central Medical Services Society (CMSS) acts as the central procurement agency for health sector goods and services as required by the ministry.
The competition watchdog dismissed the complaint after finding no 'prima facie' contravention of the Competition Act, the CCI said in an 11-page order.
On allegation of violations of the Competition Act, the regulator observed that the ministry did not fall within the definition of 'enterprise' under the competition norms as it is engaged in forming policies for health and public welfare.
The ruling came on a complaint filed by Nashik-based Cupid Ltd, a company which is engaged in manufacturing and supply of male contraceptives and has been supplying it to the ministry since 2002.
It was alleged that CMSS abused its dominant position by forcing Cupid to sign the agreement for supplying the contraceptives without negotiation and the agreement contains one-sided and unfair terms.
Besides, by imposing varied printing requirements on the product, the company alleged anti-competitive practices by CMSS, so that the products cannot be sold to any other customer.
For the case, the Competition Commission of India (CCI) considered "the market for male condoms in India as relevant" and found that CMSS cannot be considered to be a dominant player.
Regarding anti-competitive practices, the CCI said the printing and packing requirements are only in respect of the product that is to be supplied to CMSS by the company.
Moreover, conditions of the agreement neither restrict the company from dealing in goods other than those supplied to the ministry nor impose any restriction on the company to sell its goods to any buyer other than the ministry.
Hence, "the Commission finds no prima facie case of contravention of the provisions of Section 3(4) or Section 4 of the Act" against the ministry and the CMSS.
Sections 3 and 4 of the Competition Act pertain to anti-competitive practices and abuse of dominant market position, respectively.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
